NH Insider Trading Activity and SEC Form 4 Filings
NH insider trading summary
No open-market insider purchases or sales of NantHealth, Inc. (NH) have been reported on SEC Form 4 in the past 12 months.
Latest NH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 28, 2023 | Nant Capital, LLC | Insider | Buy | $10.0M (537,272 @ $18.61) |
| Aug 28, 2023 | California Capital Equity, LLC | Insider | Buy | $10.0M (537,272 @ $18.61) |
| Aug 28, 2023 | Patrick Soon-Shiong | Chief Executive Officer | Buy | $10.0M (537,272 @ $18.61) |
| Aug 28, 2023 | Nant Capital, LLC | Insider | Buy | $6.0M (15,384,616 @ $0.39) |
| Aug 28, 2023 | NantWorks, LLC | Insider | Buy | $10.0M (537,272 @ $18.61) |
| Aug 28, 2023 | Patrick Soon-Shiong | Chief Executive Officer | Buy | $6.0M (15,384,616 @ $0.39) |
| Aug 28, 2023 | NantWorks, LLC | Insider | Buy | $6.0M (15,384,616 @ $0.39) |
| Aug 28, 2023 | California Capital Equity, LLC | Insider | Buy | $6.0M (15,384,616 @ $0.39) |
| Sep 13, 2021 | Ronald Allen Louks | Chief Operating Officer | Sell | $18K (9,200 @ $1.96) |
| Sep 10, 2021 | Ronald Allen Louks | Chief Operating Officer | Sell | $15K (7,320 @ $2.05) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.